Skip to main content

Table 3 Antimicrobial prescriptions and linezolid prescriptions. Data from the national point prevalence surveys 2011 and 2016. Data comparison of the two surveys

From: Linezolid use in German acute care hospitals: results from two consecutive national point prevalence surveys

Parameter

Variable

Specification

Number (percentage)

p-value

PPS 2011

PPS 2016

Antimicrobial prescriptions (all)

  

14,076 (100)

22,086 (100)

n.a.

Linezolid prescriptions (all)

  

119 (0.8)

255 (1.2)

< 0.01

Linezolid prescriptions (all wards)

Total

 

119 (100)

255 (100)

n.a.

Dosage

2 × 600 mg

n.a.

227 (89.0)

n.a.

All other dosages

n.a.

28 (11.0)

Route of application

Parenteral

87 (73.1)

179 (70.2)

0.57

Oral

32 (26.9)

76 (29.8)

Linezolid prescriptions in non-ICU wards

Total

 

67 (56.3)

156 (61.2)

n.a.

Route of application

Parenteral

36 (53.7)

87 (55.8)

0.78

Oral

31 (46.3)

69 (44.2)

  1. P-values for variables were calculated using Chi-squared test. Bold print is used to indicate statistical significance. Abbreviations: PPS point prevalence survey, ICU intensive care unit, n.a. not available/not applicable